Asia Pacific Radiation Oncology Market Size & Outlook
Asia Pacific radiation oncology market, 2017-2028 (US$M)
Related Markets
Asia Pacific radiation oncology market highlights
- The Asia Pacific radiation oncology market generated a revenue of USD 1,527.4 million in 2020.
- The market is expected to grow at a CAGR of 7.9% from 2021 to 2028.
- In terms of segment, external beam radiationtherapy was the largest revenue generating type in 2020.
- Internal Beam Radiation Therapy is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Japan is expected to register the highest CAGR from 2021 to 2028.
Asia Pacific data book summary
| Market revenue in 2020 | USD 1,527.4 million |
| Market revenue in 2028 | USD 2,803.8 million |
| Growth rate | 7.9% (CAGR from 2020 to 2028) |
| Largest segment | External beam radiationtherapy |
| Fastest growing segment | Internal Beam Radiation Therapy |
| Historical data covered | 2017 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | External Beam RadiationTherapy, Internal Beam Radiation Therapy |
| Key market players worldwide | Siemens Healthineers AG ADR, Elekta AB ADR, BD, Accuray Inc, IBA RadioPharma Solutions, IsoRay, MeVis Medical Solutions AG, Nordion, Ntp Radioisotopes, Curium Pharma, ViewRay |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 20.1% of the global radiation oncology market in 2020.
- Globally, North America is projected to lead the regional market in terms of revenue in 2028.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,803.8 million by 2028.
External beam radiationtherapy was the largest segment with a revenue share of 74.26% in 2020. Horizon Databook has segmented the Asia Pacific radiation oncology market based on external beam radiationtherapy, internal beam radiation therapy covering the revenue growth of each sub-segment from 2017 to 2028.
The market is expected to witness lucrative growth over the forecast period. Increase in initiatives undertaken by governments to raise awareness about treatment options & diseases, growth in demand for sophisticated therapies, and increase in prevalence of cancer are some of the key factors responsible for market growth in this region.
In addition, introduction of new technologies is likely to propel market growth over the forecast period. In March 2019, BLK Super Specialty Hospital Delhi launched the first Radixact 9 TomoTherapy for treatment of cancer. In January 2019, Apollo Hospitals launched the first proton therapy center in south-east Asia.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Radiation Oncology Market Scope
Radiation Oncology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific radiation oncology market size, by country, 2017-2028 (US$M)
Asia Pacific Radiation Oncology Market Outlook Share, 2020 & 2028 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
